BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9472621)

  • 1. Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa.
    Bourillot PY; Waltzer L; Sergeant A; Manet E
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():363-70. PubMed ID: 9472621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA.
    Waltzer L; Perricaudet M; Sergeant A; Manet E
    J Virol; 1996 Sep; 70(9):5909-15. PubMed ID: 8709211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth.
    Cooper A; Johannsen E; Maruo S; Cahir-McFarland E; Illanes D; Davidson D; Kieff E
    J Virol; 2003 Jan; 77(2):999-1010. PubMed ID: 12502816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
    J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical.
    Maruo S; Johannsen E; Illanes D; Cooper A; Zhao B; Kieff E
    J Virol; 2005 Aug; 79(16):10171-9. PubMed ID: 16051810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.
    Radkov SA; Bain M; Farrell PJ; West M; Rowe M; Allday MJ
    J Virol; 1997 Nov; 71(11):8552-62. PubMed ID: 9343213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
    Sjöblom A; Nerstedt A; Jansson A; Rymo L
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa).
    Robertson ES; Lin J; Kieff E
    J Virol; 1996 May; 70(5):3068-74. PubMed ID: 8627785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription.
    Radkov SA; Touitou R; Brehm A; Rowe M; West M; Kouzarides T; Allday MJ
    J Virol; 1999 Jul; 73(7):5688-97. PubMed ID: 10364319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
    Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.
    Sjöblom A; Jansson A; Yang W; Laín S; Nilsson T; Rymo L
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2679-92. PubMed ID: 7595375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
    Zhao B; Sample CE
    J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth.
    Calderwood MA; Lee S; Holthaus AM; Blacklow SC; Kieff E; Johannsen E
    Virology; 2011 May; 414(1):19-25. PubMed ID: 21440926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.
    Maruo S; Wu Y; Ito T; Kanda T; Kieff ED; Takada K
    Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4419-24. PubMed ID: 19237563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1.
    Lee S; Sakakibara S; Maruo S; Zhao B; Calderwood MA; Holthaus AM; Lai CY; Takada K; Kieff E; Johannsen E
    J Virol; 2009 Dec; 83(23):12368-77. PubMed ID: 19776126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.
    Strobl LJ; Höfelmayr H; Stein C; Marschall G; Brielmeier M; Laux G; Bornkamm GW; Zimber-Strobl U
    Immunobiology; 1997 Dec; 198(1-3):299-306. PubMed ID: 9442401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular forms of human NOTCH1 interact at distinctly different levels with RBP-jkappa in human B and T cells.
    Callahan J; Aster J; Sklar J; Kieff E; Robertson ES
    Leukemia; 2000 Jan; 14(1):84-92. PubMed ID: 10637481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions.
    Rowe M; Raithatha S; Shannon-Lowe C
    J Virol; 2014 Oct; 88(20):12065-76. PubMed ID: 25122803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.
    Hsieh JJ; Hayward SD
    Science; 1995 Apr; 268(5210):560-3. PubMed ID: 7725102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters.
    Höfelmayr H; Strobl LJ; Stein C; Laux G; Marschall G; Bornkamm GW; Zimber-Strobl U
    J Virol; 1999 Apr; 73(4):2770-80. PubMed ID: 10074124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.